Overview of Experimental Models of the Blood‐Brain Barrier in CNS Drug Discovery

作者: Alan M. Palmer , Mohammad S. Alavijeh

DOI: 10.1002/0471141755.PH0715S62

关键词:

摘要: The blood-brain barrier (BBB) is a physical and metabolic entity that isolates the brain from systemic circulation. consists of tight junctions between endothelial cells contain egress transporters catabolic enzymes. To cross BBB, drug must possess appropriate physicochemical properties to achieve sufficient time-concentration profile in interstitial fluid (ISF). In this overview, we review techniques measure BBB permeation, which evidenced by free concentration compound ISF over time. We consider number measurement techniques, including vivo microdialysis receptor occupancy following perfusion. Consideration also given nonendothelial cell systems used assess both permeation test its interactions with transporters, computer models employed for predicting passive probability transporters.

参考文章(141)
C. Rodemer, V. Haucke, Clathrin/AP-2-dependent endocytosis: a novel playground for the pharmacological toolbox? Handbook of experimental pharmacology. ,vol. 186, pp. 105- 122 ,(2008) , 10.1007/978-3-540-72843-6_5
Sukriti Nag, Morphology and Properties of Astrocytes Methods in Molecular Biology. ,vol. 686, pp. 69- 100 ,(2011) , 10.1007/978-1-60761-938-3_3
Michael Aschner, Vanessa A. Fitsanakis, Ana Paula Marreilha dos Santos, Luisa Olivi, Joseph P. Bressler, Blood-Brain Barrier and Cell-Cell Interactions: Methods for Establishing In Vitro Models of the Blood-Brain Barrier and Transport Measurements Methods of Molecular Biology. ,vol. 341, pp. 1- 15 ,(2006) , 10.1385/1-59745-113-4:1
William A Sheremata, Alireza Minagar, J Steven Alexander, Timothy Vollmer, The role of alpha-4 integrin in the aetiology of multiple sclerosis: current knowledge and therapeutic implications. CNS Drugs. ,vol. 19, pp. 909- 922 ,(2005) , 10.2165/00023210-200519110-00002
Istvan A Krizbai, Imola Wilhelm, Csilla Fazakas, In vitro models of the blood-brain barrier. Acta Neurobiologiae Experimentalis. ,vol. 71, pp. 113- 128 ,(2011)
Peter T Sage, Christopher V Carman, Settings and mechanisms for trans-cellular diapedesis Frontiers in Bioscience. ,vol. 14, pp. 5066- 5083 ,(2009) , 10.2741/3587
N. Joan Abbott, Ehsan U. Khan, Christopher M. S. Rollinson, Andreas Reichel, Damir Janigro, Stephen M. Dombrowski, Michael S. Dobbie, David J. Begley, Drug resistance in epilepsy: the role of the blood-brain barrier. Novartis Foundation symposium. ,vol. 243, pp. 38- 53 ,(2002) , 10.1002/0470846356.CH4
Britta Engelhardt, Birgit Kempe, Stephanie Merfeld-Clauss, Melanie Laschinger, Bruce Furie, Martin K. Wild, Dietmar Vestweber, P-selectin glycoprotein ligand 1 is not required for the development of experimental autoimmune encephalomyelitis in SJL and C57BL/6 mice. Journal of Immunology. ,vol. 175, pp. 1267- 1275 ,(2005) , 10.4049/JIMMUNOL.175.2.1267